Literature DB >> 12546841

Rapid molecular theranostics in infectious diseases.

François J Picard1, Michel G Bergeron.   

Abstract

The increasing availability of rapid and sensitive nucleic acid testing assays for infectious diseases will revolutionize the practice of medicine by gradually reducing the need for standard culture-based microbiological methods that take at least two days. Molecular theranostics in infectious diseases is an emerging concept in which molecular biology tools are used to provide rapid and accurate diagnostic assays to enable better initial management of patients and more efficient use of antimicrobials. Essential conditions and the quality control required for the development and validation of such molecular theranostic assays are reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12546841     DOI: 10.1016/s1359-6446(02)02497-2

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  25 in total

Review 1.  Development and applications of photo-triggered theranostic agents.

Authors:  Prakash Rai; Srivalleesha Mallidi; Xiang Zheng; Ramtin Rahmanzadeh; Youssef Mir; Stefan Elrington; Ahmat Khurshid; Tayyaba Hasan
Journal:  Adv Drug Deliv Rev       Date:  2010-09-19       Impact factor: 15.470

2.  Individual differences in metabolomics: individualised responses and between-metabolite relationships.

Authors:  Jeroen J Jansen; Ewa Szymańska; Huub C J Hoefsloot; Age K Smilde
Journal:  Metabolomics       Date:  2012-03-15       Impact factor: 4.290

3.  Application of immobilized synthetic anti-lipopolysaccharide peptides for the isolation and detection of bacteria.

Authors:  N Sandetskaya; B Engelmann; K Brandenburg; D Kuhlmeier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-19       Impact factor: 3.267

4.  Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles.

Authors:  Shaun D Gittard; Philip R Miller; Ryan D Boehm; Aleksandr Ovsianikov; Boris N Chichkov; Jeremy Heiser; John Gordon; Nancy A Monteiro-Riviere; Roger J Narayan
Journal:  Faraday Discuss       Date:  2011       Impact factor: 4.008

5.  The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts.

Authors:  Daniel S Wagner; Nikki A Delk; Ekaterina Y Lukianova-Hleb; Jason H Hafner; Mary C Farach-Carson; Dmitri O Lapotko
Journal:  Biomaterials       Date:  2010-07-14       Impact factor: 12.479

6.  Internal control for nucleic acid testing based on the use of purified Bacillus atrophaeus subsp. globigii spores.

Authors:  François J Picard; Martin Gagnon; Marthe R Bernier; Nicholas J Parham; Martine Bastien; Maurice Boissinot; Régis Peytavi; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

Review 7.  Laboratory detection of group B Streptococcus for prevention of perinatal disease.

Authors:  F J Picard; M G Bergeron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-16       Impact factor: 3.267

8.  Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications.

Authors:  Dmitri Lapotko
Journal:  Nanomedicine (Lond)       Date:  2009-10       Impact factor: 5.307

9.  Tunable plasmonic nanobubbles for cell theranostics.

Authors:  E Y Lukianova-Hleb; E Y Hanna; J H Hafner; D O Lapotko
Journal:  Nanotechnology       Date:  2010-01-25       Impact factor: 3.874

Review 10.  Nutritional lipidomics: molecular metabolism, analytics, and diagnostics.

Authors:  Jennifer T Smilowitz; Angela M Zivkovic; Yu-Jui Yvonne Wan; Steve M Watkins; Malin L Nording; Bruce D Hammock; J Bruce German
Journal:  Mol Nutr Food Res       Date:  2013-07-01       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.